超级增强子与肥胖相关代谢性疾病的研究进展

王同帅, 郭锡熔

中国儿童保健杂志 ›› 2025, Vol. 33 ›› Issue (10) : 1079-1081.

PDF(429 KB)
PDF(429 KB)
中国儿童保健杂志 ›› 2025, Vol. 33 ›› Issue (10) : 1079-1081. DOI: 10.11852/zgetbjzz2025-0299
儿童代谢性疾病专栏

超级增强子与肥胖相关代谢性疾病的研究进展

  • 王同帅, 郭锡熔
作者信息 +

Super enhancers in obesity-related metabolic diseases

  • WANG Tongshuai, GUO Xirong
Author information +
文章历史 +

摘要

超级增强子(SE)是基因组中重要的大片段顺式调控元件,通过显著增强基因转录效率发挥基因调控作用。细胞内数百个SE协同调控大量关键基因,其异常活化与糖尿病、炎症和肿瘤等多种疾病的发生密切相关。然而,SE在代谢性疾病中的调控机制研究仍相对滞后。代谢性疾病不仅是多种慢性病的早期诱因,也是肿瘤发生的关键风险因素,被视为疾病发生的“共同土壤”。深入研究SE在代谢性疾病中的作用机制,可为完善疾病防治策略提供科学依据。本文就SE在代谢性疾病中的作用与机制进行综述,以期为开展相关基础研究和开拓临床应用提供依据。

Abstract

Super-enhancers (SEs) are specialized DNA elements that significantly enhance transcriptional efficiency, driving the expression of genes essential for cellular function.Each cell contains hundreds of SEs, which regulate key gene networks.Dysregulation of SEs has been implicated in the aberrant activation of pathogenic genes in diseases such as Alzheimer's, diabetes, inflammation, and cancer.Despite their significance, the role of SEs in metabolism-related diseases remains underexplored.Metabolic disorders often serve as foundational factors in the development of other chronic conditions.Understanding the involvement of SEs in the initiation and progression of metabolic diseases could provide critical insights and inform the development of effective prevention strategies.This review explores the emerging role of SEs in metabolic disorders and their potential as targets for therapeutic intervention.

关键词

超级增强子 / 肥胖 / 转录调控 / 调节元件 / 代谢性疾病

Key words

super-enhancers / obesity / transcription / regulatory elements / metabolism

引用本文

导出引用
王同帅, 郭锡熔. 超级增强子与肥胖相关代谢性疾病的研究进展[J]. 中国儿童保健杂志. 2025, 33(10): 1079-1081 https://doi.org/10.11852/zgetbjzz2025-0299
WANG Tongshuai, GUO Xirong. Super enhancers in obesity-related metabolic diseases[J]. Chinese Journal of Child Health Care. 2025, 33(10): 1079-1081 https://doi.org/10.11852/zgetbjzz2025-0299
中图分类号: R179   

参考文献

[1] Hnisz D, Abraham BJ, Lee TI, et al.Super-enhancers in the control of cell identity and disease[J].Cell, 2013, 155(4): 934-947.
[2] Whyte WA, Orlando DA, Hnisz D, et al.Master transcription factors and mediator establish super-enhancers at key cell identity genes[J].Cell, 2013, 153(2): 307-319.
[3] Cao HB, Zhuo R, Zhang ZM, et al.Super-enhancer-associated INSM2 regulates lipid metabolism by modulating mTOR signaling pathway in neuroblastoma[J].Cell Biosci, 2022, 12(1): 1.
[4] Zhang F, Li Z, Fang F, et al.IRF1 is a core transcriptional regulatory circuitry member promoting AML progression by regulating lipid metabolism[J].Exp Hematol Oncol, 2025, 14(1): 25.
[5] Selivanovskiy AV, Molodova MN, Khrameeva EE, et al.Liquid condensates: A new barrier to loop extrusion?[J].Cell Mol Life Sci, 2025, 82(1): 80.
[6] Zhang S, Wang C, Qin S, et al.Analyzing super-enhancer temporal dynamics reveals potential critical enhancers and their gene regulatory networks underlying skeletal muscle development[J].Genome Res, 2024, 34(12): 2190-2202.
[7] Yang RY, Wu YY, Ming Y, et al.A super-enhancer maintains homeostatic expression of Regnase-1[J].Gene, 2018, 669: 35-41.
[8] Peng JY, Cai DK, Zeng RL, et al.Upregulation ofsuperenhancer-driven LncRNA FASRL by USF1 promotes de novo fatty acid biosynthesis to exacerbate hepatocellular carcinoma[J].Adv Sci, 2022, 10(1): e2204711.
[9] Lai B, Lee JE, Jang Y, et al.MLL3/MLL4 are required for CBP/p300 binding on enhancers and super-enhancer formation in brown adipogenesis[J].Nucleic Acids Res, 2017, 45(11): 6388-6403.
[10] Watanabe-Takano H, Ochi H, Chiba A, et al.Mechanical load regulates bone growth via periosteal osteocrin[J].Cell Rep, 2021, 36(2): 109380.
[11] Hnisz D, Abraham BJ, Lee TI, et al.Super-enhancers in the control of cell identity and disease[J].Cell, 2013, 155(4): 934-947.
[12] Kuo T, Kraakman MJ, Damle M, et al.Identification of as a human diabetes susceptibility gene with a role in β cell insulin secretion[J].Proc Natl Acad Sci USA, 2019, 116(40): 20033-20042.
[13] Chim SM, Howell K, Dronzek J, et al.Genetic inactivation of zinc transporter SLC39A5 improves liver function and hyperglycemia in obesogenic settings[J].Elife, 2024, 12: 1.
[14] Sengupta S, George RE.Super-enhancer-driven transcriptional dependencies in cancer[J].Trends Cancer, 2017, 3(4): 269-281.
[15] Zhang LY, Wang CY, Xu Q, et al.Removal of epigenetic repressive mark on inflammatory genes in fat liver[J].J Gastroenterol Hepatol, 2023, 38(8): 1426-1437.
[16] Liu M, Cao S, He L, et al.Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis[J].Nat Commun, 2021, 12(1): 4560.
[17] Bartolome A.Stem cell-derived beta cells: A versatile research platform to interrogate the genetic basis of beta cell dysfunction[J].Int J Mol Sci, 2022, 23(1): 1.
[18] Ma H, Qu J, Pang Z, et al.Super-enhancer omics in stem cell[J].Mol Cancer, 2024, 23(1): 153.
[19] Xu X, Brasier AR.SMARCA4 regulates inducible BRD4 genomic redistribution coupling intrinsic immunity and plasticity in epithelial injury-repair[J].Nucleic Acids Res, 2025, 53(6): 1.
[20] Wang C, Tian W, Hu SY, et al.Lineage-selective super enhancers mediate core regulatory circuitry during adipogenic and osteogenic differentiation of human mesenchymal stem cells[J].Cell Death Dis, 2022, 13(10): 866.
[21] Rothhammer V, Mascanfroni ID, Bunse L, et al.Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor[J].Nat Med, 2016, 22(6): 586-597.

基金

国家重点研发计划(2021YFC2701900;2021YFC2701903);国家自然科学基金项目(82170869)

PDF(429 KB)

Accesses

Citation

Detail

段落导航
相关文章

/